杏林製薬の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2014/06/19 | 2,005 | 2,034 | 2,000 | 2,027 | +34 | +1.7% | 249,600 |
2014/06/18 | 1,964 | 1,997 | 1,961 | 1,993 | +39 | +2% | 210,100 |
2014/06/17 | 1,960 | 1,967 | 1,948 | 1,954 | -1 | -0.1% | 117,000 |
2014/06/16 | 1,960 | 1,963 | 1,944 | 1,955 | -5 | -0.3% | 86,700 |
2014/06/13 | 1,937 | 1,965 | 1,936 | 1,960 | +6 | +0.3% | 158,800 |
2014/06/12 | 1,962 | 1,967 | 1,936 | 1,954 | -8 | -0.4% | 96,800 |
2014/06/11 | 1,944 | 1,966 | 1,934 | 1,962 | +26 | +1.3% | 131,100 |
2014/06/10 | 1,970 | 1,971 | 1,931 | 1,936 | -29 | -1.5% | 198,000 |
2014/06/09 | 1,976 | 1,979 | 1,962 | 1,965 | +3 | +0.2% | 76,500 |
2014/06/06 | 1,967 | 1,968 | 1,946 | 1,962 | -7 | -0.4% | 107,800 |
2014/06/05 | 1,987 | 1,989 | 1,959 | 1,969 | -6 | -0.3% | 67,700 |
2014/06/04 | 1,977 | 1,998 | 1,955 | 1,975 | -7 | -0.4% | 124,300 |
2014/06/03 | 1,984 | 1,988 | 1,961 | 1,982 | +7 | +0.4% | 140,500 |
2014/06/02 | 1,980 | 1,988 | 1,968 | 1,975 | +11 | +0.6% | 137,900 |
2014/05/30 | 1,945 | 1,979 | 1,945 | 1,964 | +23 | +1.2% | 191,300 |
2014/05/29 | 1,949 | 1,970 | 1,936 | 1,941 | -9 | -0.5% | 108,500 |
2014/05/28 | 1,945 | 1,977 | 1,922 | 1,950 | +29 | +1.5% | 252,700 |
2014/05/27 | 1,917 | 1,945 | 1,917 | 1,921 | -14 | -0.7% | 134,400 |
2014/05/26 | 1,922 | 1,940 | 1,898 | 1,935 | +27 | +1.4% | 117,400 |
2014/05/23 | 1,916 | 1,932 | 1,899 | 1,908 | +12 | +0.6% | 218,100 |
2014/05/22 | 1,873 | 1,898 | 1,863 | 1,896 | +37 | +2% | 157,100 |
2014/05/21 | 1,850 | 1,868 | 1,847 | 1,859 | -2 | -0.1% | 187,300 |
2014/05/20 | 1,860 | 1,880 | 1,852 | 1,861 | -4 | -0.2% | 155,800 |
2014/05/19 | 1,879 | 1,892 | 1,860 | 1,865 | -2 | -0.1% | 82,600 |
2014/05/16 | 1,881 | 1,887 | 1,851 | 1,867 | -42 | -2.2% | 149,600 |
2014/05/15 | 1,921 | 1,922 | 1,881 | 1,909 | -30 | -1.5% | 132,700 |
2014/05/14 | 1,915 | 1,949 | 1,904 | 1,939 | +36 | +1.9% | 186,500 |
2014/05/13 | 1,919 | 1,950 | 1,896 | 1,903 | -8 | -0.4% | 237,200 |
2014/05/12 | 1,957 | 1,969 | 1,908 | 1,911 | -42 | -2.2% | 243,500 |
2014/05/09 | 1,950 | 1,996 | 1,830 | 1,953 | -16 | -0.8% | 302,300 |
2014/05/08 | 1,972 | 1,994 | 1,961 | 1,969 | +1 | +0.1% | 258,800 |
2014/05/07 | 2,000 | 2,000 | 1,953 | 1,968 | -52 | -2.6% | 229,700 |
2014/05/02 | 2,003 | 2,034 | 2,003 | 2,020 | +12 | +0.6% | 177,000 |
2014/05/01 | 1,979 | 2,016 | 1,977 | 2,008 | +36 | +1.8% | 237,100 |
2014/04/30 | 1,997 | 1,998 | 1,966 | 1,972 | -13 | -0.7% | 138,500 |
2014/04/28 | 1,967 | 1,988 | 1,954 | 1,985 | +17 | +0.9% | 240,100 |
2014/04/25 | 1,968 | 2,002 | 1,949 | 1,968 | +10 | +0.5% | 267,900 |
2014/04/24 | 1,945 | 1,970 | 1,941 | 1,958 | +12 | +0.6% | 280,500 |
2014/04/23 | 1,932 | 1,950 | 1,922 | 1,946 | +16 | +0.8% | 196,200 |
2014/04/22 | 1,925 | 1,955 | 1,917 | 1,930 | +18 | +0.9% | 231,300 |
2014/04/21 | 1,932 | 1,937 | 1,902 | 1,912 | -13 | -0.7% | 151,800 |
2014/04/18 | 1,927 | 1,935 | 1,913 | 1,925 | -1 | -0.1% | 97,800 |
2014/04/17 | 1,923 | 1,932 | 1,907 | 1,926 | +10 | +0.5% | 172,400 |
2014/04/16 | 1,911 | 1,924 | 1,901 | 1,916 | +16 | +0.8% | 155,700 |
2014/04/15 | 1,913 | 1,919 | 1,894 | 1,900 | +5 | +0.3% | 131,600 |
2014/04/14 | 1,894 | 1,932 | 1,893 | 1,895 | ±0 | ±0% | 194,800 |
2014/04/11 | 1,881 | 1,916 | 1,873 | 1,895 | +6 | +0.3% | 386,500 |
2014/04/10 | 1,914 | 1,931 | 1,882 | 1,889 | -1 | -0.1% | 364,700 |
2014/04/09 | 1,877 | 1,914 | 1,874 | 1,890 | -8 | -0.4% | 368,900 |
2014/04/08 | 1,926 | 1,940 | 1,893 | 1,898 | -33 | -1.7% | 347,400 |
2551~
2600
件表示中 / 3586件
類似銘柄と比較する
現在ご覧いただいている「杏林製薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
杏林製薬 | 149,900円 | +3.2% | +4.5% | 3.47% | 17.22倍 | 0.66倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
ゼリア新薬 | 224,400円 | +13.6% | +29.2% | 2.05% | 11.64倍 | 1.12倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
ネクセラファーマ | 113,200円 | +197.7% | - | 0.00% | 46.26倍 | 1.48倍 |
|
創薬ベンチャー老舗。買収で成長。英国の創薬事業に日本が柱の後期治験・製造販売事業加わる |
JCRファーマ | 72,400円 | -3.7% | -36.7% | 2.76% | 23.84倍 | 1.56倍 |
|
ヒト成長ホルモン製剤が主力、バイオ後続品も成長。希少疾病のバイオ新薬開発にも取り組む |
栄研化 | 209,200円 | +0.4% | -8.4% | 2.53% | 27.65倍 | 1.57倍 |
|
臨床検査薬大手。便潜血検査試薬(FIT)はシェア7割。尿検査(ウロ)、遺伝子検査も育成 |
市場注目の銘柄
チャート関連のコラム